网络研讨会: 摒弃动物疫苗批放行试验。中国的机会和正在进行的活动

Note: The workshop will be in Chinese. Chinese description follows English version below.

REGISTER / 登记 : https://zoom.us/webinar/register/WN_UVHAPbvgTi6-LWjJEz5IDg

The webinar series is part of the Humane World for Animals project “Promoting implementation plans for replacement of animal testing for human vaccines” (link), a 3-year project aiming to accelerate the implementation and regulatory acceptance of non-animal approaches for legacy human vaccine batch-release testing with a specific focus on BRICS countries, advancing the dialogue toward global regulatory alignment while generating local implementation plans and competencies.

The webinar aims to provide an overview of the status of the development of in vitro methodologies and approaches for the safety and potency tests performed for the human vaccines batch release, with a specific focus on the opportunities and projects that Chinese stakeholders are working on or taking into consideration for future applications: in vitro potency tests (Rabies, HPV), in vitro bacterial endotoxin tests (recombinant Factor C), in vitro safety or obsolete testing deletion (Abnormal Toxicity Test) or many others.

Humane World for Animals has been collaborating with R&D-based Pharmaceutical Association Committee

(RDPAC) and Council for the Promotion of International Vaccine Cooperation (CPIVC) for the creation of this webinar.

Agenda

About Humane World for Animals and the Animal Free Safety Assessment Collaboration.

Advancing the welfare of animals in more than 50 countries, Humane Society International works around the globe to promote the human-animal bond, rescue and protect dogs and cats, improve farm animal welfare, protect wildlife, promote animal-free testing and research, respond to disasters and confront cruelty to animals in all of its forms.

Within its effort to promote animal-free testing and research, HSI Research&Toxicology department have been collaborating with industry and regulatory stakeholders in the field of medicine, chemicals, cosmetics and biomedical research creating the multistakeholders’ Animal Free Safety Assessment Collaboration. AFSA brings together corporate and non-profit leaders who share the goal of accelerating a modern, species-relevant approach to safety assessment globally to better protect people and our planet, and hasten the replacement of animal testing.

The collaboration has been successfully acting as an independent facilitator or ‘honest broker’ for the project “Deletion or Waiving of Abnormal Toxicity and Target Animal Batch Safety Tests” project.

Over the past few years, AFSA has worked to position itself as a supportive and complementary player, offering a valuable contribution to address a significant gap in the sector:

• Making sure that an ever-growing number of stakeholders can be engaged, informed and supported in accepting and becoming actors of the change with regard to modern, animal-free vaccine safety tests
• Establishing a wider climate of international cooperation where the experiences of those who have already succeeded can become beacons – and proof-of-concept/precedent – for those still lagging behind

Together with its member, the International Alliance for Biological Standardization, IABS, AFSA organizes events since the global meeting in Bangkok in December 2019 and have since intensified their exchanges on non-animal-based testing (other examples of webinars and workshops are available).

CHINESE

摒弃动物疫苗批放行试验。中国的机会和正在进行的活动

网络研讨会 Zoom
仅限中文
2025年4月16日

该系列网络研讨会是“人道世界动物保护项目——推动替代动物试验的实施计划”项目的一部分（链接），该项目为期三年，旨在加速非动物方法在传统人类疫苗批放行测试中的实施和法规接受，特别聚焦于金砖国家，推动全球法规的一致性，同时制定本地实施计划和能力建设。

该网络研讨会旨在概述人用疫苗批放行所需的安全性和效价测试的体外方法及其发展现状，特别关注中国利益相关者正在研究或考虑的未来应用机会和项目：体外效价测试（狂犬病、HPV）、体外细菌内毒素测试（重组因子C）、体外安全性或淘汰过时试验（异常毒性试验）等。

人道世界动物保护项目与研发型制药协会委员会（RDPAC）和国际疫苗合作促进委员会（CPIVC）合作，共同创建了这一系列网络研讨会。

议程